Determining cell type abundance and expression from bulk tissues with digital cytometry
2019 · Nature Biotechnology · 4,603 citations
https://doi.org/10.1038/s41587-019-0114-2
M
Mohammad Shahrokh Esfahani
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
146
Papers
11.4K
Citations
28
h-index
40
i10-index
Mohammad Shahrokh Esfahani is an academic researcher from Stanford Medicine. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & Lymphoma Diagnosis and Treatment. The author has an h-index of 28, co-authored 125 publications.
ORCID: 0000-0002-0950-3937Papers by this author
worksCirculating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
2016 · Nature Communications · 650 citations
https://doi.org/10.1038/ncomms11815
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA
2021 · Nature Biotechnology · 343 citations
https://doi.org/10.1038/s41587-021-00981-w
Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling
2023 · Nature · 92 citations
https://doi.org/10.1038/s41586-023-06903-x
Incorporating biological prior knowledge for Bayesian learning via maximal knowledge-driven information priors
2017 · BMC Bioinformatics · 43 citations
https://doi.org/10.1186/s12859-017-1893-4
Probabilistic reconstruction of the tumor progression process in gene regulatory networks in the presence of uncertainty
2011 · BMC Bioinformatics · 15 citations
https://doi.org/10.1186/1471-2105-12-s10-s9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat